Literature DB >> 10475264

Exposure to hyperbaric oxygen induces cell cycle perturbation in prostate cancer cells.

J E Kalns1, E H Piepmeier.   

Abstract

Cell cycle synchronization of tumor cells by exposure to hyperbaric oxygenation (HBO) may increase the efficacy of chemotherapy or radiation by placing cells into a chemosensitive portion of the cycle. The purpose of the current study was to examine oxygen pressure-dependent relationships with respect to the cell cycle in prostate tumor cells in vitro. LNCaP cells were grown in an incubator at 21% O2 and then exposed to 100% oxygen at pressures up to 6 atmospheres (atm) for 1.5 h. Cells were then returned to the incubator and evaluated for DNA content by propidium iodide and new DNA synthesis with a pulse-chase experiment. Cell cycle effects were evaluated by flow cytometry. Exposure to HBO increased the percentage of cells synthesizing new DNA in a dose-dependent fashion: 0 atm, 44%; 6 atm, 65%. Cells that synthesize new DNA accumulate in G2/M as a function of partial pressure of oxygen. These results suggest that HBO induces cells to enter the cell cycle and accumulate in G2/M. Cell cycle synchronization and entry of senescent cells into the cell cycle suggest that HBO may be a useful adjuvant to chemotherapy or radiation in the treatment of prostate cancer. There are two potential mechanisms of action that may make HBO efficacious in the treatment of prostate cancer. HBO may potentiate cancer chemotherapeutic agents that cause damage to DNA during DNA synthesis or HBO may inhibit cell division causing accumulation in G2/M.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10475264     DOI: 10.1007/s11626-999-0008-6

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  28 in total

1.  Effects of hyperoxia on human endothelial cell proliferation and morphology in vitro.

Authors:  R Bjerkvig; J Thorsen; E Svendsen; H Holmsen; T Thorsen
Journal:  Undersea Biomed Res       Date:  1992-11

2.  Cell response to hyperbaric oxygen treatment.

Authors:  P C Tompach; D Lew; J L Stoll
Journal:  Int J Oral Maxillofac Surg       Date:  1997-04       Impact factor: 2.789

Review 3.  Current status of high linear energy transfer irradiation.

Authors:  M P Richter; G E Laramore; T W Griffin; R L Goodman
Journal:  Cancer       Date:  1984-12-01       Impact factor: 6.860

4.  Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.

Authors:  B A Teicher; J M Crawford; S A Holden; K N Cathcart
Journal:  Cancer Res       Date:  1987-10-01       Impact factor: 12.701

Review 5.  Prostate cancer treatment strategies based on tumor-specific biological principles: future directions.

Authors:  M A Carducci; T L DeWeese; W G Nelson; J W Simons; V Sinibaldi; M A Eisenberger
Journal:  Semin Oncol       Date:  1996-12       Impact factor: 4.929

Review 6.  Hyperbaric oxygen in the radiation treatment of head and neck cancers.

Authors:  R Sealy
Journal:  Radiother Oncol       Date:  1991       Impact factor: 6.280

Review 7.  Metabolic and clonogenic consequences of ischaemia reperfusion insult in solid tumours.

Authors:  C S Parkins; S A Hill; M R Stratford; M F Dennis; D J Chaplin
Journal:  Exp Physiol       Date:  1997-03       Impact factor: 2.969

8.  Hyperbaric oxygen therapy and squamous cell carcinoma cell line growth.

Authors:  D Sklizovic; J R Sanger; E P Kindwall; J G Fink; B K Grunert; B H Campbell
Journal:  Head Neck       Date:  1993 May-Jun       Impact factor: 3.147

9.  Stimulation of glycosaminoglycan synthesis in cultured fibroblasts by hyperbaric oxygen.

Authors:  G P Roberts; K G Harding
Journal:  Br J Dermatol       Date:  1994-11       Impact factor: 9.302

10.  Cancer statistics, 1995.

Authors:  P A Wingo; T Tong; S Bolden
Journal:  CA Cancer J Clin       Date:  1995 Jan-Feb       Impact factor: 508.702

View more
  9 in total

Review 1.  Hyperbaric oxygen therapy for malignancy: a review.

Authors:  Jurstine Daruwalla; Chris Christophi
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

Review 2.  Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics.

Authors:  Qiaoyu Fu; Ran Duan; Yu Sun; Qingfeng Li
Journal:  Redox Biol       Date:  2022-05-27       Impact factor: 10.787

3.  Change of oxygen pressure in glioblastoma tissue under various conditions.

Authors:  Takaaki Beppu; Katsura Kamada; Yuki Yoshida; Hiroshi Arai; Kuniaki Ogasawara; Akira Ogawa
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

4.  Topical oxygen therapy induces vascular endothelial growth factor expression and improves closure of clinically presented chronic wounds.

Authors:  Gayle M Gordillo; Sashwati Roy; Savita Khanna; Richard Schlanger; Sorabh Khandelwal; Gary Phillips; Chandan K Sen
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-04-21       Impact factor: 2.557

5.  Severity of hematuria effects resolution in patients treated with hyperbaric oxygen therapy for radiation-induced hematuria.

Authors:  Michael A Liss; Kathryn Osann; Jane Cho; Walter C Chua; Atreya Dash
Journal:  Urol Int       Date:  2013-08-06       Impact factor: 2.089

Review 6.  Hyperbaric oxygen therapy and cancer--a review.

Authors:  Ingrid Moen; Linda E B Stuhr
Journal:  Target Oncol       Date:  2012-10-02       Impact factor: 4.493

7.  Synergistic inhibitory effect of hyperbaric oxygen combined with sorafenib on hepatoma cells.

Authors:  Hai-Shan Peng; Ming-Bin Liao; Mei-Yin Zhang; Yin Xie; Li Xu; Yao-Jun Zhang; X F Steven Zheng; Hui-Yun Wang; Yi-Fei Chen
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

8.  Hyperbaric Oxygen Potentiates Doxil Antitumor Efficacy by Promoting Tumor Penetration and Sensitizing Cancer Cells.

Authors:  Xian Wu; Yanhong Zhu; Wei Huang; Jingqiu Li; Bixiang Zhang; Zifu Li; Xiangliang Yang
Journal:  Adv Sci (Weinh)       Date:  2018-06-25       Impact factor: 16.806

Review 9.  Further application of hyperbaric oxygen in prostate cancer.

Authors:  Qi-Zhong Lu; Xiang Li; Jun Ouyang; Jin-Quan Li; Gang Chen
Journal:  Med Gas Res       Date:  2019-01-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.